Moncef Slaoui's Net Worth

$0

Estimate Recalculated Jul 12, 2024 06:01PM EST

Who is Moncef Slaoui?

Moncef Slaoui does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Moderna, Inc., Intellia Therapeutics, Inc., and Vaxcyte, Inc..

SEC CIK

Moncef Slaoui's CIK is 0001712369

Past Insider Trading and Trends

2017 was Moncef Slaoui's most active year for acquiring shares with 1 total transactions. Moncef Slaoui's most active month to acquire stocks was the month of March. 2019 saw Moncef Slaoui paying a total of $0.00 for 54,660 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Moderna, Inc. (MRNA) Snapshot price: $99.335

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Apr 29
Form 4
0
0
Jun 27
Form 3
0
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jul 25
Form 3
0
0
No matching records found

Vaxcyte, Inc. (PCVX) Snapshot price: $73.9345

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Arcturus Therapeutics Holdings Inc. (ARCT) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 19
Form 3
0
0
No matching records found